Related references
Note: Only part of the references are listed.Global patterns and trends in colorectal cancer incidence and mortality
Melina Arnold et al.
GUT (2017)
Dual association of serum interleukin-10 levels with colorectal cancer
Shabnam Abtahi et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2017)
Posttranscriptional regulation of Galectin-3 by miR-128 contributes to colorectal cancer progression
Weiqun Lu et al.
ONCOTARGET (2017)
Synergistic interaction between galectin-3 and carcinoembryonic antigen promotes colorectal cancer metastasis
Keng-Liang Wu et al.
ONCOTARGET (2017)
Galectin-3 expression in colorectal cancer and its correlation with clinical pathological characteristics and prognosis
Liu Tao et al.
OPEN MEDICINE (2017)
The impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastases
Armin Wiegering et al.
PLOS ONE (2017)
Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients
Ruzica Lukic et al.
DISEASE MARKERS (2017)
Galectin-3 in Renal Pathology: More Than Just an Innocent Bystander?
Valerie Desmedt et al.
AMERICAN JOURNAL OF NEPHROLOGY (2016)
Diagnostic Accuracy of Five Different Fecal Markers for the Detection of Precancerous and Cancerous Lesions of the Colorectum
Mariann Rutka et al.
MEDIATORS OF INFLAMMATION (2016)
Validation of an enzyme-linked immunosorbent assay (ELISA) for the measurement of canine S100A12
Romy M. Heilmann et al.
VETERINARY CLINICAL PATHOLOGY (2016)
Circulating Galectin-1 and 90K/Mac-2BP Correlated with the Tumor Stages of Patients with Colorectal Cancer
Keng-Liang Wu et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Potential Dual Immunomodulatory Role of VEGF in Ulcerative Colitis and Colorectal Carcinoma
Natasa D. Zdravkovic et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2014)
Immune reaction and colorectal cancer: Friends or foes?
Vincenzo Formica et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Colorectal cancer and immunity: what we know and perspectives
Simon Pernot et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Extracellular galectin-3 in tumor progression and metastasis
Anneliese Fortuna-Costa et al.
FRONTIERS IN ONCOLOGY (2014)
Meta-analyses of colorectal cancer risk factors
Constance M. Johnson et al.
CANCER CAUSES & CONTROL (2013)
Therapeutic guidelines on ulcerative colitis: A GRADE methodology based effort of GETECCU
Fernando Gomollon et al.
GASTROENTEROLOGIA Y HEPATOLOGIA (2013)
Overexpression of galectin-3 enhances migration of colon cancer cells related to activation of the K-Ras-Raf-Erk1/2 pathway
Keng-Liang Wu et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
Axel Dignass et al.
JOURNAL OF CROHNS & COLITIS (2012)
Memory Type 2 Helper T Cells Induce Long-Lasting Antitumor Immunity by Activating Natural Killer Cells
Masayuki Kitajima et al.
CANCER RESEARCH (2011)
Cytokines, Inflammation and Colon Cancer
L. Klampfer
CURRENT CANCER DRUG TARGETS (2011)
Colorectal tumors: The histology report
Giovanni Lanza et al.
DIGESTIVE AND LIVER DISEASE (2011)
Galectin-3 and the skin
Larissa Larsen et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2011)
Does colon cancer ever metastasize to bone first? a temporal analysis of colorectal cancer progression
Eira S. Roth et al.
BMC CANCER (2009)
Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse
Huan-Yuan Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Screening Options and Recommendations for Colorectal Cancer
Timothy Geiger et al.
Clinics in Colon and Rectal Surgery (2009)
Tumor-associated galectin-3 modulates the function of tumor-reactive T cells
Weiyi Peng et al.
CANCER RESEARCH (2008)
Polarized immune responses differentially regulate cancer development
Magnus Johansson et al.
IMMUNOLOGICAL REVIEWS (2008)
Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease
Michael Wagner et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Regulation of Tumor Progression by Extracellular Galectin-3
Pratima Nangia-Makker et al.
CANCER MICROENVIRONMENT (2008)
Epidemiology of colorectal cancer: the 21-year experience of a specialised registry
M. Ponz de Leon et al.
INTERNAL AND EMERGENCY MEDICINE (2007)
Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia
Kim D. Johnson et al.
NEOPLASIA (2007)
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis
Geert D'Haens et al.
GASTROENTEROLOGY (2007)
Disrupted galectin-3 causes non-alcoholic fatty liver disease in male mice
K. Nomoto et al.
JOURNAL OF PATHOLOGY (2006)
Advanced glycation end products - Sparking the development of diabetic vascular injury
Alison Goldin et al.
CIRCULATION (2006)
Flow Cytometric analysis of Th1 and Th2 cytokines in PBMCs as a parameter of immunological dysfunction in patients of Superficial Transitional cell carcinoma of bladder
A Agarwal et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The metabolic burden of diabetes and dyslipidaemia in chronic kidney disease
V Krane et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation
JN Primrose
GUT (2002)
Galectin-3 and carcinoembryonic antigen expression in medullary thyroid carcinoma: possible relation to tumour progression
D Cvejic et al.
HISTOPATHOLOGY (2000)
A simple method for assessing intestinal inflammation in Crohn's disease
J Tibble et al.
GUT (2000)
A reproducible grading scale for histological assessment of inflammation in ulcerative colitis
K Geboes et al.
GUT (2000)
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
JA Tibble et al.
GASTROENTEROLOGY (2000)
Share Paper
